Christopher D Verrico, Ph.D.
Picture
Positions
- Associate Professor
-
Psychiatry Research
Baylor College of Medicine
Houston, TX US
Addresses
- Michael E. DeBakey Veterans Affairs Medical Center (Office)
-
2002 Holcombe Blvd
Building 100
Houston, TX 77030
United States
Phone: (713) 791-1414
verrico@bcm.edu
Education
- Postdoctoral Fellowship at University Of Pittsburgh
- Pittsburgh, Pennsylvania United States
- Department of Psychiatry, Translational Neuroscience Program
- Postdoctoral Fellowship at Carnegie Mellon University
- Pittsburgh, Pennsylvania United States
- Search Results Web Result with Site Links Center for Neural Basis of Cognition
- Postdoctoral Fellowship at Harvard Medical School
- Southborough, Massachusetts United States
- Department of Psychiatry, Division of Neurochemistry
- Postdoctoral Fellowship at Yale University School Of Medicine
- New Haven, Connecticut United States
- Department of Psychiatry
- BS from University Of Pittsburgh
- 01/1995 - Pittsburgh, Pennsylvania United States
- Neuroscience
- PhD from Yale University
- 01/2002 - New Haven, Connecticut United States
- Pharmacology
Websites
Selected Publications
- Verrico CD, Gu H, Peterson ML, Sampson AR, Lewis DA. "Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory.." American J Psychiatry. 2014 Apr;171(4):416-25. Pubmed PMID: 24577206
- Verrico CD, Liu S, Bitler EJ, Gu H, Sampson AR, Bradberry CW, Lewis DA "Delay- and dose-dependent effects of d(9)-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys.." Neuropsychopharmacology. 2012 May;37(6):1357-66. Pubmed PMID: 22218091
- Verrico CD, Liu S, Asafu-Adjei JK, Sampson AR, Bradberry CW, Lewis DA "Acquisition and baseline performance of working memory tasks by adolescent rhesus monkeys.." Brain Res.. 2011 Mar 10;1378:91-104. Pubmed PMID: 21215729
- Volk DW, Siegel BI, Verrico CD, Lewis DA "Endocannabinoid metabolism in the prefrontal cortex in schizophrenia.." Schizophr. Res.. 2013 Jun;147(1):53-7. Pubmed PMID: 23561296
- Eggan SM, Stoyak SR, Verrico CD, Lewis DA "Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.." Neuropsychopharmacology. 2010 Sep;35(10):2060-71. Pubmed PMID: 20555313
- Verrico CD, Jentsch JD, Roth RH, Taylor JR "Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention.." Neuropsychopharmacology. 2004 Mar;29(3):522-9. Pubmed PMID: 14694348
- Verrico CD, Jentsch JD, Roth RH "Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats.." Synapse. 2003 Jul;49(1):61-6. Pubmed PMID: 12710016
- Verrico CD, Jentsch JD, Dazzi L, Roth RH "Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat.." Synapse. 2003 Jun 15;48(4):178-83. Pubmed PMID: 12687636
- Jentsch JD, Dazzi L, Chhatwal JP, Verrico CD, Roth RH "Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.." Neurosci. Lett.. 1998 Dec 24;258(3):175-8. Pubmed PMID: 9885959
- Jentsch JD, Verrico CD, Le D, Roth RH "Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.." Neurosci. Lett.. 1998 May 1;246(3):169-72. Pubmed PMID: 9792619
- George TP, Picciotto MR, Verrico CD, Roth RH "Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects.." Biol. Psychiatry. 2001 Feb 1;49(3):300-6. Pubmed PMID: 11230881
- George TP, Verrico CD, Xu L, Roth RH "Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms.." Neuropsychopharmacology. 2000 Jul;23(1):79-88. Pubmed PMID: 10869888
- George TP, Verrico CD, Picciotto MR, Roth RH "Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization.." J. Pharmacol. Exp. Ther.. 2000 Oct;295(1):58-66. Pubmed PMID: 10991961
- George TP, Verrico CD, Roth RH "Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress.." Brain Res.. 1998 Aug 10;801(41276):36-49. Pubmed PMID: 9729261
- Verrico CD, Lynch L, Fahey MA, Fryer AK, Miller GM, Madras BK "MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.." J. Psychopharmacol. (Oxford). 2008 Mar;22(2):187-202. Pubmed PMID: 18308800
- Verrico CD, Miller GM, Madras BK "MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.." Psychopharmacology (Berl.). 2007 Jan;189(4):489-503. Pubmed PMID: 16220332
- Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, Madras BK "Primate trace amine receptor 1 modulation by the dopamine transporter.." J. Pharmacol. Exp. Ther.. 2005 Jun;313(3):983-94. Pubmed PMID: 15764732
- Verrico CD, Mahoney JJ 3rd, Thompson-Lake DG, Bennett RS, Newton TF, De La Garza R 2nd "Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.." Int J Neuropsychopharmacol. 2014 Feb;17(2):223-33. Pubmed PMID: 24393456
- Verrico CD, Haile CN, Mahoney JJ 3rd, Thompson-Lake DG, Newton TF, De La Garza R 2nd "Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.." Drug Alcohol Depend.. 2014 Aug;141:72-8. Pubmed PMID: 24928479
- Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R 2nd. "Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.." Expert Opin Investig Drugs. 2013;22(12):1549-68. Pubmed PMID: 24033127
Log In to edit your profile
